首页> 外文期刊>Oncology reports >miR-138 suppresses the proliferation of oral squamous cell carcinoma cells by targeting Yes-associated protein 1
【24h】

miR-138 suppresses the proliferation of oral squamous cell carcinoma cells by targeting Yes-associated protein 1

机译:miR-138通过靶向Yes相关蛋白1抑制口腔鳞状细胞癌细胞的增殖

获取原文
获取原文并翻译 | 示例
           

摘要

Aberrant microRNA expression has been suggested to be an important event in the pathologies of various types of cancer. MicroRNA-138 (miR-138) has been reported to be frequently downregulated in various types of human cancer, including oral squamous cell carcinoma (OSCC). However, the precise molecular mechanism of miR-138 underlying OSCC remains largely unknown. The aim of the present study was to investigate the expression of miR-138 in OSCC tumor tissues and several OSCC cell lines and validated its interaction with the 3'-untranslated region (3'-UTR) of Yes-associated protein 1 (YAP1). The results showed that, miR-138 was significantly downregulated in OSCC tumor tissues and cell lines. Overexpression of miR-138 inhibited cell proliferation of OSCC cells whereas the downregulation of miR-138 promoted cell proliferation. A direct interaction between miR-138 and 3'-UTR of YAP1 was validated by dual-luciferase reporter assay. Moreover, overexpression of miR-138 in OSCC cells significantly decreased the expression of YAP1 and downregulation of miR-138 inhibited the expression of YAP1. Specifically, the inhibitory effect of miR-138 on the proliferation of OSCC cells was eliminated by transfection with YAP1 overexpression vectors that did not harbor any specific miR-138 binding specific sequences in 3'-UTR. In addition, the miR-138-overexpressing OSCC cells exhibited a low growth rate in the xenograft tumor assay with a decreased expression of YAP1 in tumor tissues. The results suggest that miR-138 is a tumor suppressor miRNA in OSCC through targeting YAP1, which serves as a promising therapeutic target for the treatment of OSCC.
机译:有人提出异常的microRNA表达是各种类型癌症的病理学中的重要事件。据报道,MicroRNA-138(miR-138)在包括口腔鳞状细胞癌(OSCC)在内的各种类型的人类癌症中经常被下调。然而,miR-138潜在OSCC的精确分子机制仍是未知之数。本研究的目的是研究miR-138在OSCC肿瘤组织和几种OSCC细胞系中的表达,并验证其与Yes-associated蛋白1(YAP1)的3'-非翻译区(3'-UTR)的相互作用。 。结果表明,miR-138在OSCC肿瘤组织和细胞系中显着下调。 miR-138的过表达抑制OSCC细胞的细胞增殖,而miR-138的下调则促进细胞增殖。通过双荧光素酶报告基因分析验证了miR-138和YAP1的3'-UTR之间的直接相互作用。而且,miR-138在OSCC细胞中的过表达显着降低了YAP1的表达,而miR-138的下调抑制了YAP1的表达。具体地,通过用YAP1过表达载体转染消除了miR-138对OSCC细胞增殖的抑制作用,所述YAP1过表达载体在3'-UTR中不具有任何特定的miR-138结合特异性序列。此外,miR-138过表达的OSCC细胞在异种移植肿瘤分析中显示出低生长速率,而在肿瘤组织中的YAP1表达却降低了。结果表明,miR-138通过靶向YAP1是OSCC中的抑癌miRNA,可作为有望治疗OSCC的治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号